RT Journal Article
SR Electronic
T1 Use of a systems engineering framework to assess perceptions and practices about antimicrobial resistance of workers on large dairy farms in Wisconsin
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.28.20221747
DO 10.1101/2020.10.28.20221747
A1 Ashley E. Kates
A1 Mary Jo Knobloch
A1 Ali Konkel
A1 Amanda Young
A1 Andrew Steinberger
A1 John Shutske
A1 Pamela L. Ruegg
A1 Ajay K. Sethi
A1 Tony Goldberg
A1 Juliana Leite de Campos
A1 Garret Suen
A1 Nasia Safdar
YR 2020
UL http://medrxiv.org/content/early/2020/11/03/2020.10.28.20221747.abstract
AB We studied farmworker practices potentially contributing to transmission of bacteria and antimicrobial resistant genes (ARGs) among animals and farm workers to identify human behavioral interventions to reduce exposure risk. Ten focus groups were conducted on eight farms to explore potentially high-risk practices and farmworker knowledge and experiences with antimicrobial use and resistance using the Systems Engineering in Patient Safety (SEIPS) framework. Farmworkers were asked to describe common tasks and the policies guiding these practices. We found workers demonstrated knowledge of the role of antibiotic stewardship in preventing the spread of ARGs. Knowledge of various forms of personal protective equipment was higher for workers who commonly reported glove-use. Knowledge regarding the importance of reducing ARG transmission varied but was greater than previously reported. Programs to reduce ARG spread on dairy farms should focus on proper hand hygiene and personal protective equipment use but at the level of knowledge, beliefs, and practices.Competing Interest StatementDr. Ruegg reports personal fees from Boehringer-Ingelheim Animal Health, outside the submitted work.Funding StatementFunding was supplied by USDA-NIFA Food Safety Challenge Grant 2017-68003-26500. AEK was supported by a National Library of Medicine training grant to the Computation and Informatics in Biology and Medicine Training Program, USA (NLM 5T15LM007359). NS is supported grant number R01HS026226 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study documents and activities were approved by the University of Wisconsin-Madison Institutional Review Board (application ID: 2017-1333) prior to the start of research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data is available upon reasonable request to the corresponding author.